Switch to:
GuruFocus has detected 3 Warning Signs with Sangamo Therapeutics Inc $SGMO.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Sangamo Therapeutics Inc (NAS:SGMO)
Additional Paid-In Capital
$582.60 Mil (As of Mar. 2017)

Sangamo Therapeutics Inc's quarterly additional paid-in capital increased from Sep. 2016 ($574.34 Mil) to Dec. 2016 ($576.38 Mil) and increased from Dec. 2016 ($576.38 Mil) to Mar. 2017 ($582.60 Mil).

Sangamo Therapeutics Inc's annual additional paid-in capital increased from Dec. 2014 ($534.52 Mil) to Dec. 2015 ($560.99 Mil) and increased from Dec. 2015 ($560.99 Mil) to Dec. 2016 ($576.38 Mil).


Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Sangamo Therapeutics Inc Annual Data

AdditionalPaidInCapital 221.18228.76263.96272.95332.84339.85423.21534.52560.99576.38

Sangamo Therapeutics Inc Quarterly Data

AdditionalPaidInCapital 534.52540.64545.24558.04560.99564.37571.55574.34576.38582.60
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)